Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Celebrity red carpet appearances at the SAG Awards have reignited concerns about their noticeably slimmer figures and fueled ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...

Discover how Madison Burgess, a Michigan native, transformed her weight loss journey with Ozempic and micro-dosing techniques ...

Wegovy, a drug that is FDA approved for weight loss, has the same active ingredient as Ozempic (semaglutide). Wegovy contains higher doses of semaglutide, which works to regulate hunger.

Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...

Gift 5 articles to anyone you choose each month when you subscribe. Novo Nordisk, the Danish pharmaceutical giant that makes Wegovy, says as many as 3.5 million Australians could be eligible to ...

For customers using a telehealth website to get cheaper versions of popular obesity drugs, the low prices turned out to be too good to be true. Customers of Zappy Health tell NPR they were drawn ...

38,734 people played the daily Crossword recently. Can you solve it faster than others?38,734 people played the daily Crossword recently. Can you solve it faster than others? Now That Trump Has ...

A new study has found that semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with AUD. Despite the availability of treatment options ...

From the March/April 2025 issue of Car and Driver. You'd think the sight of a new MG might attract more attention, whether it was spied carving up the winding roads of rural Scotland or whizzing ...